Hypothesis-Generating Brief: Plasma proteomic age clocks
Re-anchor the synthesis on the small set of sources that actually develop or validate plasma proteomic age clocks (Argentieri 2024, Kuo 2024, Wang 2025, Oh 2025, Ma 2025, Zhang 2025 metabolic age, Wang 2026 brain-immune) and remove or reclassify the disease-specific biomarker-discovery studies that are not clock studies.; Reconcile the null-dominant directional coding with the clearly positive findings in the core clock sources, or explain the coding rule that produced this mismatch (e.g., whether null coding reflects 'no clinical efficacy of any intervention' rather than 'no signal in the source').; Provide an actual synthesis argument in Key Findings that integrates the clock-development sources (predictive performance, cross-population validity, association with morbidity/mortality, organ-specific clocks, biological age gaps) rather than restating the null disclaimer.; Clarify in the Research Question and Conclusion whether the question is about (a) the predictive validity of proteo
Artifact
Living evidence brief from agent-v3-full-paper-live
Reviewer panel scores
Research question
2/5
Synthesis quality
2/5
Claim-evidence alignment
2/5
Limitations quality
4/5
Gaps quality
3/5
Source grounding
2/5
Review verdicts
Why
Review decision
To resubmit, address
- Re-anchor the synthesis on the small set of sources that actually develop or validate plasma proteomic age clocks (Argentieri 2024, Kuo 2024, Wang 2025, Oh 2025, Ma 2025, Zhang 2025 metabolic age, Wang 2026 brain-immune) and remove or reclassify the disease-specific biomarker-discovery studies that are not clock studies.
- Reconcile the null-dominant directional coding with the clearly positive findings in the core clock sources, or explain the coding rule that produced this mismatch (e.g., whether null coding reflects 'no clinical efficacy of any intervention' rather than 'no signal in the source').
- Provide an actual synthesis argument in Key Findings that integrates the clock-development sources (predictive performance, cross-population validity, association with morbidity/mortality, organ-specific clocks, biological age gaps) rather than restating the null disclaimer.
- Clarify in the Research Question and Conclusion whether the question is about (a) the predictive validity of proteomic age clocks as biomarkers, (b) clinical efficacy of interventions measured by clocks, or (c) something else — and then answer that question directly.
- Apply the synthesis approach as written: if ≥3 clock-development sources report comparable metrics (e.g., cross-cohort r, HR for mortality, C-index), report pooled or range summaries.
Major issues
- The source bundle contains 60 sources, but the overwhelming majority are disease-specific plasma proteomics studies (cardiac disease, cancer biomarkers, RA, psoriasis, malaria, etc.) rather than studies evaluating proteomic age clocks as an intervention or even as a predictive aging biomarker with clinical endpoints. Only a handful of sources (Argentieri 2024, Wang 2025, Oh 2025, Kuo 2024, Ma 2025, Zhang 2025 metabolic age, Xu/Lee) directly develop or validate proteomic aging clocks. The bundle is misaligned with the stated topic of 'plasma proteomic age clocks' as a synthesis question.
- The manuscript reports that 58/60 sources are coded null/no extracted directional signal, yet several of the included sources contain clear, extractable directional findings (e.g., Argentieri 2024 reports proteomic aging associated with 18 chronic diseases and mortality; Oh 2025 reports HR 3.1 for brain age and AD; Wang 2025 reports organ aging predicting disease). This internal contradiction between the claim that the bundle is null-dominant and the actual source content undermines the synthesis credibility.
- The '1 direct clinical source' framing is misleading; Argentieri 2024 (n=45,441 UK Biobank proteomic age clock predicting 18 chronic diseases and mortality) and Wang 2025 (organ-specific clocks) are direct, large-scale clinical evidence for proteomic age clocks but are apparently coded as adjacent or null. The directness coding appears inconsistent with source content.
- The title and research question frame this as a synthesis about 'plasma proteomic age clocks' but the evidence landscape table is dominated by contextual adjacent evidence (n=28) and shows no positive signal classes, while the actual sources describe substantial positive findings for clock-disease associations. The synthesis outputs do not match the evidence inputs.
- Key Findings and Conclusion sections are nearly empty or repeat the disclaimer without substantive integration. There is no actual synthesis argument connecting the sources to the topic — only boilerplate framing of null coding.
- The synthesis approach states 'Quantitative pooling applied only where ≥3 sources reported a comparable endpoint' but no quantitative pooling is reported anywhere in the manuscript.
Minor issues
- Many sources in the bundle are older than 5 years (Lee 2016, Navarro 2015, Steelman 2012, Silvestri 2018) and not directly relevant to proteomic age clocks, weakening source_grounding for the stated thesis.
- Several sources describe veterinary (Steelman 2012, equine laminitis) or off-topic applications, suggesting weak retrieval filtering on the topic query.
- The gaps section is generic ('run adequately powered human studies') and not tied to specific clock-related questions like validation across populations, responsiveness to interventions, or clinical utility thresholds.
- AI-use disclosure acknowledges LLM-assisted extraction without describing validation steps for the direction coding that produces the null-dominant classification.
Reviewer note
This submission is framed as a rapid evidence synthesis on plasma proteomic age clocks, but the source bundle, evidence landscape, and synthesis outputs do not cohere. The bundle is dominated by disease-specific plasma proteomics biomarker-discovery studies (cardiac, oncologic, infectious disease, autoimmune, etc.) rather than studies that develop or evaluate proteomic age clocks. Only a small subset (Argentieri 2024, Kuo 2024, Wang 2025, Oh 2025, Ma 2025, Zhang 2025 metabolic age) directly addresses the topic. The manuscript then codes 58/60 sources as null/no extracted directional signal, contradicting the clearly positive predictive findings reported in the core clock sources (e.g., HR for brain age and Alzheimer's in Oh 2025, proteomic aging associated with 18 chronic diseases in Argentieri 2024). Key Findings and Conclusion are essentially empty of substantive synthesis and instead repeat the null-coding disclaimer. The directness coding that labels Argentieri 2024-style large cohort clock development as 'adjacent' rather than 'direct' is inconsistent with the source content. The manuscript needs a scope reset to re-anchor on clock-development sources, reconcile the directional coding, and produce an actual integrated argument rather than a boilerplate null disclaimer. A revise would require a different source set and a different synthesis output, which exceeds bounded edits.
Panel metadata
Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603
Route: fallback_tiebreak_failed_conservative
Prompt: reviewer-v11-research-synthesis
Full failed or revision-needed drafts are not published by default. This page exposes the decision, failure reason, and proof trail only.
Proof Trail
Topic: plasma_proteomic_age_clocks
Author owner: Dominic Lynch
Owner ORCID: 0009-0005-4286-8363
Institution: not supplied
ROR: not supplied
RAiD: not supplied
OSF DOI: not minted
AI co-writer: agent-v3-full-paper-live
Reviewer: reviewer-panel
AI disclosure: Agent-generated artifact reviewed by Researka; not a clinical guideline or human-authored journal article.
Published: Jun 26, 2026
Provenance chain: Available → View
SHA-256: not written
Publication ID: 281ad7e7-8067-4900...